首页> 外国专利> SUBSTITUTED 2 - PYRIMIDINYL - 6,7,8,9 - TETRAHYDROPYRIMIDO {1,2-A} PYRIMIDIN - 4 - ONE AND 7 -PYRIMIDINYL - 2,3 - DIHYDROIMIDAZO {1,2-A} PYRIMIDIN - 5 (1H) ONE DERIVATIVES FOR NEURODEGENERATIVE DISORDERS

SUBSTITUTED 2 - PYRIMIDINYL - 6,7,8,9 - TETRAHYDROPYRIMIDO {1,2-A} PYRIMIDIN - 4 - ONE AND 7 -PYRIMIDINYL - 2,3 - DIHYDROIMIDAZO {1,2-A} PYRIMIDIN - 5 (1H) ONE DERIVATIVES FOR NEURODEGENERATIVE DISORDERS

机译:替换2-吡咯烷酮-6,7,8,9-四氢吡咯并咪唑{1,2-A}吡咯烷酮-4-一对和7-吡咯烷酮-2,3-二氢吡喃咪唑{1,2-A}吡咯烷酮-5(1H)一个神经退行性疾病的衍生物

摘要

The invention relates to use of a pyrimidone derivative represented by formula (I) or a salt thereof as therapeutic agents: Wherein m, n, p, X, Y, R1, R2, R3, R4 R5, are as defined herein. The invention specifically relates to a medicament comprising the said derivative or a salt thereof as an active ingredient which is used for preventive and/or therapeutic treatment of a neurodegenerative disease caused by abnormal activity of GSK3 or GSK3 and cdk5/p25, such as Alzheimer disease.
机译:本发明涉及式(I)代表的嘧啶酮衍生物或其盐作为治疗剂的用途:其中,m,n,p,X,Y,R 1,R 2,R 3,R 4 R 5如本文所定义。本发明具体涉及包含所述衍生物或其盐作为有效成分的药物,该药物用于预防和/或治疗由GSK3或GSK3和cdk5 / p25的异常活性引起的神经退行性疾病,例如阿尔茨海默氏病。 。

著录项

  • 公开/公告号IL160397A

    专利类型

  • 公开/公告日2009-07-20

    原文格式PDF

  • 申请/专利号IL20040160397

  • 发明设计人

    申请日2004-02-15

  • 分类号A61K31/519;A61P3/04;A61P3/10;A61P9/10;A61P17/02;A61P17/14;A61P19/08;A61P21/04;A61P25;A61P25/02;A61P25/08;A61P25/16;A61P25/18;A61P25/20;A61P25/24;A61P25/28;A61P25/34;A61P27/02;A61P27/06;A61P35;A61P35/02;C07D487/04;

  • 国家 IL

  • 入库时间 2022-08-21 19:27:46

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号